Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of 0.15% UF-021 in Patients With Retinitis Pigmentosa
jRCT2080220721Phase 2
- Sponsor
- R-Tech Ueno
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of unoprostone isopropyl in retinitis pigmentosa (RP), sponsored by R-Tech Ueno.
02
Drugs
unoprostone isopropyl
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on jRCT2080220721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220721.